Latest Johnson & Johnson Stories
-- COMPANY REJECTS OFFER, TAKES ADDITIONAL STEPS TO END J&J'S TEST STRIP MONOPOLY LOS ANGELES, May 19, 2015 /PRNewswire/ -- Decision Diagnostics Corp.
First Carotid Stent Indicated for Transcarotid Use and Optimized for Novel TransCarotid Artery Revascularization (TCAR) Procedure SUNNYVALE, Calif., May 19, 2015 /PRNewswire/ -- Silk
93% of patients treated with INVEGA TRINZA(TM) remained relapse-free at the end of long-term maintenance trial TITUSVILLE, N.J., May 19, 2015 /PRNewswire/ -- There's a new treatment option
Healthcare Company Names Operation Smile a 'Signature Partner' at 13th Annual Smile Event NEW YORK, May 18, 2015 /PRNewswire/ -- Hundreds gathered Thursday night at Cipriani 42(nd)
Findings Also Show Some Patients Discontinue Use of Other Blood-Glucose-Lowering Medications after Initiation of INVOKANA® RARITAN, N.J., May 18, 2015 /PRNewswire/ -- Janssen Pharmaceuticals,
Results Add to Findings from Ongoing Five-Year Post-Marketing Safety Program of XARELTO® Use in Clinical Practice NATIONAL HARBOR, Md., May 15, 2015 /PRNewswire/ -- New data from an ongoing
VENTURE-AF, the First Global, Prospective, Randomized Trial of Any Novel Oral Anticoagulant in this Setting, Presented as Late-Breaking Clinical Trial RARITAN, N.J., May 14, 2015 /PRNewswire/
TITUSVILLE, N.J., May 11, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. announced today that the U.S.
Expanded Policy will Increase Access for Darunavir Pediatric Formulations in 128 Resource-Limited Countries RARITAN, N.J., May 11, 2015 /PRNewswire/ -- Johnson & Johnson today
Attorneys representing women and families in St.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).